hotspot -WSS

hotspot

author：hotspot 2025-09-29 04:23:16 - browse：38274

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Europe sees delivery challenges ahead on Alzheimer's therapies

Wikipedia

leisure time

WSS

Bernie Sanders bashes nonprofit hospitals over their tax breaks

STAT Readout Newsletter: Today in biotech, life science news

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Does aspartame cause cancer? What new WHO guidance says

There’s no way to know how good AI health technologies are

How doctors and nurses shape Google's AI

Wikipedia

hotspot

focus

Medicare proposal to cover medical devices draws a mixed reaction

A fraught question for the kids of Alzheimer’s: Is it coming for us?

BioMarin wins approval for gene therapy to treat hemophilia A

Global childhood vaccinations edge closer to pre

Wildfire smoke exposes gaps in outdoor worker protections

Involuntary treatment for addiction doesn't work

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Who gets to use the title 'doctor'?

Apple is now the first public company to be valued at $3 trillion

Congress likely to miss an opportunity to fix drug shortages issue

Wikipedia

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Peter Marks talks Operation Warp Speed for Rare Diseases

Blood tests recalled over risk of missed heart attack diagnosis

Massive project maps cells in human brain in unprecedented detail

Argenx drug significantly slows progression of nerve disorder

Researchers CRISPR chickens in bid to protect them from bird flu

Wikipedia

leisure time

leisure time

leisure time